← Back to Search
The Orphan Nuclear Receptor SXR Coordinately Regulates Drug Metabolism And Efflux
T. Synold, I. Dussault, B. M. Forman
Published 2001 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Cytochrome P450 3A4 is an important mediator of drug catabolism that can be regulated by the steroid and xenobiotic receptor (SXR). We show here that SXR also regulates drug efflux by activating expression of the gene MDR1, which encodes the protein P-glycoprotein (ABCB1). Paclitaxel (Taxol), a commonly used chemotherapeutic agent, activated SXR and enhanced P-glycoprotein–mediated drug clearance. In contrast, docetaxel (Taxotere), a closely related antineoplastic agent, did not activate SXR and displayed superior pharmacokinetic properties. Docetaxel's silent properties reflect its inability to displace transcriptional corepressors from SXR. We also found that ET-743, a potent antineoplastic agent, suppressed MDR1 transcription by acting as an inhibitor of SXR. These findings demonstrate how the molecular activities of SXR can be manipulated to control drug clearance.
This paper references
Biochemistry and molecular biology of the human CYP2C subfamily.
J. Goldstein (1994)
Unique response pathways are established by allosteric interactions among nuclear hormone receptors
B. M. Forman (1995)
Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues.
R. McKinnon (1995)
15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ
B. M. Forman (1995)
Isolation and characterization of a new cDNA clone belonging to the cytochrome P450 2C gene subfamily in hamsters.
T. Sakuma (1995)
Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs.
I. Royer (1996)
The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
T. A. Jackson (1997)
Antitumor activity of docetaxel.
J. Eckardt (1997)
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.
A. Sparreboom (1997)
Pharmacology of the Taxanes
R. Dorr (1997)
Pharmacokinetics of the Taxanes
C. Kearns (1997)
Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.
C. L. Smith (1997)
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
B. Forman (1997)
Biotransformation of taxoids by human cytochromes P450: structure-activity relationship.
B. Monsarrat (1997)
In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients.
E. Izbicka (1998)
Preclinical pharmacokinetics of paclitaxel and docetaxel.
A. Sparreboom (1998)
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
S. Kliewer (1998)
SXR, a novel steroid and xenobiotic-sensing nuclear receptor.
B. Blumberg (1998)
Androstane metabolites bind to and deactivate the nuclear receptor CAR-β
B. Forman (1998)
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
R. M. Lavinsky (1998)
Induction of cytochrome P4503A by taxol in primary cultures of human hepatocytes.
V. Kostrubsky (1998)
Human cytochrome P450s: selectivity and measurement in vivo.
D. Smith (1998)
Biochemical, cellular, and pharmacological aspects of the multidrug transporter.
S. Ambudkar (1999)
The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue.
Helmut Dotzlaw (1999)
Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.
H. Wang (1999)
Clinical Pharmacokinetics of Docetaxel
S. Clarke (1999)
Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743.
E. J. Martinez (1999)
Molecular mechanisms of cytochrome P-450 induction by xenobiotics: An expanded role for nuclear hormone receptors.
U. Savas (1999)
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
L. B. Moore (2000)
Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation.
S. Jin (2000)
Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands*
L. B. Moore (2000)
P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.
M. Pallis (2000)
Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes.
J. Pascussi (2000)
Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743.
M. Minuzzo (2000)
Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation.
A. Ruth (2000)
The coregulator exchange in transcriptional functions of nuclear receptors.
C. Glass (2000)
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
S. Jones (2000)
The taxanes: an update
J. Crown (2000)
St John's wort, a herbal antidepressant, activates the steroid X receptor.
J. M. Wentworth (2000)
Humanized xenobiotic response in mice expressing nuclear receptor SXR
W. Xie (2000)
Combinatorial Roles of the Nuclear Receptor Corepressor in Transcription and Development
K. Jepsen (2000)
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Jeff L. Staudinger (2001)
The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse
H. Masuyama (2001)
This paper is referenced by
Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment
Aikaterini Skandalaki (2021)
Effect of Vitamin K-Mediated PXR Activation on Drug-Metabolizing Gene Expression in Human Intestinal Carcinoma LS180 Cell Line
H. Sultana (2021)
Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review
Baddipadige Raju (2021)
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming.
L. Mosca (2021)
Megestrol acetate is a specific inducer of CYP3A4 mediated by human pregnane X receptor
Yakun Chen (2021)
Z-guggulsterone regulates MDR1 expression mainly through the pregnane X receptor-dependent manner in human brain microvessel endothelial cells.
H. Xu (2020)
Mutation of a single amino acid of pregnane X receptor switches an antagonist to agonist by altering AF-2 helix positioning
Andrew D. Huber (2020)
Flavonoid-Mediated Modulation of CYP3A Enzyme and P-Glycoprotein Transporter: Potential Effects on Bioavailability and Disposition of Tyrosine Kinase Inhibitors
M. Iqbal (2020)
Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells
Yun Soo Jeong (2020)
PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches
Jingheng Wang (2020)
Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review)
Stella Baliou (2020)
Citrus auraptene induces drug efflux transporter P-glycoprotein expression in human intestinal cells.
T. Nabekura (2020)
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance?
A. Dalpiaz (2020)
Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein
T. Nabekura (2020)
Low dose HSP90 inhibition with AUY922 blunts rapid evolution of metastatic and drug resistant phenotypes induced by TGF-β and paclitaxel in A549 cells.
Nickolas A. Bacon (2020)
Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor
Wenqi Cui (2020)
Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
Ingrid Lilienthal (2020)
Characterization of an Alginate Encapsulated LS180 Spheroid Model for Anti-colorectal Cancer Compound Screening.
T. Smit (2020)
Associations between Pregnane X Receptor and Breast Cancer Growth and Progression
B. Creamer (2020)
Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P 450 3 A 4 in human hepatocytes
Jian Yang (2019)
BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation.
Drishti Rathod (2019)
Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy.
Changlong Liu (2019)
Fucoidan-coated coral-like Pt nanoparticles for computed tomography-guided highly enhanced synergistic anticancer effect against drug-resistant breast cancer cells.
Seounghun Kang (2019)
Functional role of miR-148a in oropharyngeal cancer: influence on pregnane X receptor and P-glycoprotein expression
T. Reuter (2019)
TMEM213 as a novel prognostic and predictive biomarker for patients with lung adenocarcinoma after curative resection: a study based on bioinformatics analysis.
Jia-Yun Zou (2019)
Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.
Guoyu Pan (2019)
TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR
Ella Bhagyaraj (2019)
Genetic associations of docetaxel‐based chemotherapy‐induced myelosuppression in Chinese Han population
Weihua Ren (2019)
Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance.
Chao-Yun Cai (2019)
Marine Ligands of the Pregnane X Receptor (PXR): An Overview
Alejandro Carazo (2019)
Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes
Maarten van Eijk (2019)
Multiple Modes of Vitamin K Actions in Aging-Related Musculoskeletal Disorders
K. Azuma (2019)See more